Medical Communications

Showing 15 posts of 6417 posts found.

Otsuka receives positive CHMP opinion for lupus nephritis treatment

July 22, 2022 Medical Communications

The CHMP has adopted a positive opinion relating to the use of Lupkynis (voclosporin) in combination with mycophenolate mofetil for …

Cancer Research UK agreement to advance cancer immunotherapy candidate

July 22, 2022 Medical Communications

Cancer Research UK and Sosei Heptares have announced the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug …
alina-grubnyak-tevgmmapfxk-unsplash

FDA approval for neurostimulation device to treat diabetic neuropathic pain

July 15, 2022 Medical Communications

DyAnsys has received FDA approval for its First Relief device, a wearable device monitoring pulses of a low-level electrical current …

Step strategy effective in treating diabetic eye disease

July 15, 2022 Medical Communications

An NIH-funded clinical from the DRCR Retina Network suggests that a specific step strategy for patients with diabetic macular edema …

FDA approves new treatment for rare tumour

July 15, 2022 Medical Communications

The FDA has approved crizotinib for adult and paediatric patients aged 1 year and older with unresectable, recurrent, or refractory …

Japanese study suggests parasitic worms could deliver anti-cancer therapies

July 8, 2022 Medical Communications

Researchers from Osaka University have released details on how they discovered a unique potential treatment method for cancer: parasitic worms.The …

NICE recommends Nivolumab for invasive urothelial cancer

July 8, 2022 Medical Communications

NICE has published final draft guidance recommending nivolumab for treating some people with invasive urothelial cancer at a high risk …

New funding announced to support future dementia research

July 8, 2022 Medical Communications

The NIHR has introduced £11.8 million in funding for promising early career researchers to pursue dementia research. The institute, working …

Scientists discover key to hepatitis A replication

July 8, 2022 Medical Communications

UNC School of Medicine scientists discovered the key to hepatitis A virus (HAV) replication. They also found an oral compound …

NHS privatisation linked to rise in avoidable deaths

July 1, 2022 Medical Communications

NHS privatisation was connected to over 500 deaths from treatable diseases in England over five years, a study from Oxford …

Sirana Pharma collaborates with Pfizer to investigate rare disease treatment

July 1, 2022 Medical Communications

Sirana Pharma has announced a collaboration with Pfizer to investigate the potential identification and validation of a novel treatment concept …

HIV accelerates body’s aging soon after initial infection

July 1, 2022 Medical Communications

Scientists have discovered that accelerated aging with HIV begins at the time of initial HIV infection. Researchers found that HIV …

Scientists discover mechanism controlling spread of pancreatic cancer

June 30, 2022 Business Services, Medical Communications

New findings, published in Nature, show that a protein called GREM1 is key to regulating the type of cells found …

NIH researchers find norovirus can spread through saliva

June 30, 2022 Business Services, Medical Communications

A class of viruses known to cause severe diarrheal diseases can grow in the salivary glands of mice and spread …

FDA grant orphan drug designation to XMT-2056 for treatment of gastric cancer

May 20, 2022 Medical Communications

Mersana Theapeutics has announced that the FDA has granted orphan drug designation to XMT-2056, the company’s lead Immunosynthen STING-agonist ADC, …
The Gateway to Local Adoption Series

Latest content